These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 11573085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1.
    Meza JE, Brzovic PS, King MC, Klevit RE.
    J Biol Chem; 1999 Feb 26; 274(9):5659-65. PubMed ID: 10026184
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
    Stewart MD, Zelin E, Dhall A, Walsh T, Upadhyay E, Corn JE, Chatterjee C, King MC, Klevit RE.
    Proc Natl Acad Sci U S A; 2018 Feb 06; 115(6):1316-1321. PubMed ID: 29367421
    [Abstract] [Full Text] [Related]

  • 8. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
    Rodriguez JA, Schüchner S, Au WW, Fabbro M, Henderson BR.
    Oncogene; 2004 Mar 11; 23(10):1809-20. PubMed ID: 14647430
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
    Ghimenti C, Sensi E, Presciuttini S, Brunetti IM, Conte P, Bevilacqua G, Caligo MA.
    Genes Chromosomes Cancer; 2002 Mar 11; 33(3):235-42. PubMed ID: 11807980
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
    Thai TH, Du F, Tsan JT, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, Bowcock AM.
    Hum Mol Genet; 1998 Feb 11; 7(2):195-202. PubMed ID: 9425226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E, Irminger-Finger I.
    Int J Biochem Cell Biol; 2010 May 11; 42(5):693-700. PubMed ID: 20060929
    [Abstract] [Full Text] [Related]

  • 14. The BRCA1/BARD1 ubiquitin ligase and its substrates.
    Witus SR, Stewart MD, Klevit RE.
    Biochem J; 2021 Sep 30; 478(18):3467-3483. PubMed ID: 34591954
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
    Atipairin A, Canyuk B, Ratanaphan A.
    Breast Cancer Res Treat; 2011 Feb 30; 126(1):203-9. PubMed ID: 20878461
    [Abstract] [Full Text] [Related]

  • 17. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
    Ratajska M, Antoszewska E, Piskorz A, Brozek I, Borg Å, Kusmierek H, Biernat W, Limon J.
    Breast Cancer Res Treat; 2012 Jan 30; 131(1):89-97. PubMed ID: 21344236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.